Back to search
FDAFDA · Food and drugs·Recall number D-1450-2016

Oxacillin for Injection, USP, 10 grams per pharmacy bulk package, Buffered - For IV Use, Sterile, Nonpyrogenic, Preservative-free, Rx Only, Mfd for Sagent Pharmaceuticals, Schaumberg, IL, 60196, USA, Made in India, NDC 25021-163-69

Published August 3, 2016 · Recall initiated: June 13, 2016

Summary

FDA records drug Class II recall D-1450-2016, published August 3, 2016 and initiated June 13, 2016. Recalling firm: Sagent Pharmaceuticals Inc; Status: Terminated; Reported quantity: 3990 vials; Lot: Lot #: OXT515, Exp. July 2017. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter; The firm received two product complaints for small, dark particulate matter identified in solution post reconstitution.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Sagent Pharmaceuticals Inc
Distributor
Nationwide
Lot
Lot #: OXT515, Exp. July 2017
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Oxacillin for Injection, USP, 10 grams per pharmacy bulk package, Buffered - For IV Use, Sterile, Nonpyrogenic, Preservative-free, Rx Only, Mfd for Sagent Pharmaceuticals, Schaumberg, IL, 60196, USA, Made in India, NDC 25021-163-69 recalled?

Yes. FDA published recall D-1450-2016 on August 3, 2016. Reported hazard: Presence of Particulate Matter; The firm received two product complaints for small, dark particulate matter identified in solution post reconstitution.

What should I do if I have this product?

Voluntary: Firm initiated · Letter